Acute Myeloid Leukemia, Stem Cell Mobilization, Autologous Graft vs. Tumor Effect, CLL, Risks and Management Options for Relapse of AML Post HCT, Kidney Transplant Tolerance Protocols, Evolving Role of Biomarkers in the Management of Acute GVHD
James M. Foran, M.D., Ivana N. Micallef, M.D., Shaji Kumar, M.D., Luis F. Porrata, M.D., Nasser H. Hanna, M.D., Sameer A. Parikh, M.B.B.S., Alex Adjei, M.D., Ph.D., Daniel J. Weisdorf, M.D., Patrick B. Johnston, M.D., Ph.D., Gabriel T. Bartoo, Pharm.D., R.Ph., Helen E. Heslop, M.D., Francis K. Buadi, M.D., Nandita Khera, M.D., M.P.H., Mrinal S. Patnaik, M.B.B.S., Mark D. Stegall, M.D., Ruben A. Mesa, M.D., Saad J. Kenderian, M.B., Ch.B., William J. Hogan, M.B., B.Ch., Mark R. Litzow, M.D.
This event offers
11.0 CME credits
CE accredited by Mayo School of Continuous Professional Development.